comparemela.com

Page 8 - Drug Development Summit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlights

15.05.2023 - Received FDA clearance for investigational new drug (IND) application for lead therapeutic candidate, PMN310, in Alzheimer’s diseasePresented preclinical data supporting target identification and candidate differentiation across pipeline of antibody .

INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.